{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Data is the new currency for drug development","description":"In this episode Venkat Sethuraman, SVP Global Biometrics and Data Science, Bristol-Myers Squibb talks with Tom Lehmann about the critical role of data, design and digital in the future vision for R&amp;amp;D. ","author_name":"The Lens: Life Sciences Reinvention in Focus","author_url":"https:\/\/www.accenture.com\/us-en\/podcast\/life-sciences","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/21198281\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/450074\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/item\/21198281"}